Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia

Journal of Medical Genetics

Volumn 41, Issue 3, 2004, Pages 171-174

  Yang, Y ^a   Wang, Y ^a   Li, S ^a   Xu, Z ^b   Li, H ^c   Ma, L ^b   Fan, J ^c   Bu, D ^a   Liu, B ^d   Fan, Z ^d   Wu, G ^d   Jin, J ^a   Ding, B ^a   Zhu, X ^a   Shen, Y ^d  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VOLTAGE GATED SODIUM CHANNEL;

ADOLESCENT; ALPHA CHAIN; ARTICLE; AUTOSOMAL DISORDER; CHILD; CHINESE; CONTROLLED STUDY; ERYTHROMELALGIA; FEMALE; GENE; GENE EXPRESSION; GENE GCA; GENE MUTATION; GENETIC LINKAGE; HUMAN; LINKAGE ANALYSIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCN9A GENE; SCREENING;

EID: 12144288410     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2003.012153     Document Type: Article

References (19)

1. Drenth JP, Michiels JJ. Three types of erythromelalgia. BMJ 1990;301:454-5.
2. Uno H, Parker F. Autonomic innervation of the skin in primary erythermalgia. Arch Dermatol 1983;119:65-71.
3. Davis MD, O'Fallon WM, Rogers RS, et al. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol 2000;136:330-6.
4. Cohen IJ, Samorodin CS. Familial erythromelalgia. Arch Dermatol 1982;118:953-4.
5. Michiels JJ, Van Joost T, Vuzevski VD. Idiopathic erythermalgia: a congenital disorder. J Am Acad Dermatol 1989;21:1128-30.
6. Finley WH, Lindsey JRJ, Fine JD, et al. Autosomal dominant erythromelalgia. Am J Med Genet 1992;42:310-5.
7. Drenth JP, Finley WH, Breedveld GJ, et al. The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32. Am J Hum Genet 2001;68:1277-82.
8. Drenth JP, Michiels JJ. Erythromelalgia and erythermalgia: diagnostic differentiation. Int J Dermatol 1994;33:393-7.
9. Claes L, Del-Favero J, Ceulemans B, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001;68:1327-32.
10. Ptacek LJ, George AL Jr, Griggs RC, et al. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 1991;67:1021-7.
11. + channel alpha-subunit in hyperkalaemic periodic paralysis. Nature 1991;354:387-9.
12. Koch MC, Ricker K, Otto M, et al. Confirmation of linkage of hyperkalaemic periodic paralysis to chromosome 17. J Med Genet 1991;28:583-6.
13. Toledo-Aral JJ, Moss BL, He ZJ, et al. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci U S A 1997;94:1527-32.
14. Klugbauer N, Lacinova L, Flockerzi V, et al. Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J 1995;14:1084-90.
15. Sangameswaran L, Fish LM, Koch BD, et al. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem 1997;272:14805-9.
16. Lehmann-Horn F, Jurkat-Rott K. Voltage-gated ion channels and hereditary disease. Physiol Rev 1999;79:1317-72.
17. Felix R. Channelopathies: ion channel defects linked to heritable clinical disorders. J Med Genet 2000;37:729-40.
18. + channels. Jpn J Pharmacol 2002;88:365-77.
19. Plassart E, Eymard B, Maurs L, et al. Paramyotonia congenita: genotype to phenotype correlations in two families and repart of a new mutation in the sodium channel gene. J Neurol Sci 1996;142:126-33.